L3-7582 — Interim report
1.
Clinical biomarkers for kidney allograft rejection

The objective of this review was to provide contemporary data on the diagnostic role of laboratory test-based functional monitoring assays that can be used in everyday clinical practice and use non-invasive samples, such as peripheral blood or spot urine samples that might help distinguish rejection versus non-rejection episodes and between different rejection phenotypes as well as to predict functional recovery after anti-rejection therapy.

COBISS.SI-ID: 2885292
2.
Treatment of antibody-mediated rejection after kidney transplantation - 10 years' experience with apheresis at a single center

We aimed to analyse diagnosis, treatment and outcome of antibody-mediated kidney allograft rejection (ABMR) in a cohort of 75 patients with biopsy-proven acute or chronic active ABMR between 2000 and 2015.

COBISS.SI-ID: 3277228